Effects of Endoscopic Submucosal Dissection in Patients with Early Gastric Carcinoma on Postoperative Life Satisfaction and Serum Livin, Epidermal Growth Factor, and IL-8 Levels

Keywords

early gastric carcinoma
EGF
endoscopic submucosal dissection
IL-8
Livin

Categories

How to Cite

Xing, L., & Du, Q. . (2022). Effects of Endoscopic Submucosal Dissection in Patients with Early Gastric Carcinoma on Postoperative Life Satisfaction and Serum Livin, Epidermal Growth Factor, and IL-8 Levels. Iranian Red Crescent Medical Journal, 24(7). Retrieved from https://ircmj.com/index.php/IRCMJ/article/view/2105

Abstract

Background: Few studies have investigated the changes in postoperative quality of life; serum Livin, epidermal growth factor (EGF), and IL-8 levels; and traumatic stress in patients with early gastric carcinoma after endoscopic submucosal dissection.
Objectives: We aimed to determine the effect of endoscopic submucosal dissection on postoperative life satisfaction and serum Livin, EGF, and IL-8 levels in early gastric carcinoma patients.
Methods: Seventy-three early gastric carcinoma patients were divided into the control (n = 35) and observation (n = 38) groups based on surgical approaches and were retrospectively analyzed.
Results: The operative time, gastrointestinal recovery time, length of hospital stay, perioperative bleeding, EQ-VAS scores, GAS and MTL levels were significantly superior to those in the control group, whereas serum Livin, EGF, IL-8 and CRP levels as well as the total incidence of postoperative complications were significantly lower in the observation group than in the control group (all P < 0.05).
Conclusion: Endoscopic submucosal dissection in early gastric carcinoma patients provides the advantages of a short operative time, less perioperative bleeding, rapid postoperative recovery, and less traumatic stress and postoperative complications as well as reduced serum Livin, EGF, IL-8, and tumor marker levels.

References

Tanabe S, Ishido K, Matsumoto T, Kosaka T, Oda I, Suzuki H, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study. Gastric Cancer. 2017;20:45-52. doi: 10.1007/s10120-016-0664-7. [PMID: 27807641].

Kim SG, Ji SM, Lee NR, Park SH, You JH, Choi IJ, et al. Quality of Life after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Prospective Multicenter Cohort Study. Gut Liver. 2017;11:87-92. doi: 10.5009/gnl15549. [PMID: 27282267].

Song L, Guo Y, Xu B. Expressions of Ras Homolog Gene Family, Member A (RhoA) and Cyclooxygenase-2 (COX-2) Proteins in Early Gastric Cancer and Their Role in the Development of Gastric Cancer. Med Sci Monit. 2017;23:2979-84. doi: 10.12659/msm.902367. [PMID: 28624843].

Jeong SH, An J, Kwon KA, Lee WK, Kim KO, Chung JW, et al. Predictive risk factors associated with synchronous multiple early gastric cancer. Medicine (Baltimore). 2017;96:e7088. doi: 10.1097/MD.0000000000007088. [PMID: 28658102].

Lee JW, Lee MS, Chung IK, Son MW, Cho YS, Lee SM. Clinical implication of FDG uptake of bone marrow on PET/CT in gastric cancer patients with surgical resection. World J Gastroenterol. 2017;23:2385-95. doi: 10.3748/wjg.v23.i13.2385. [PMID: 28428718].

Probst A, Ebigbo A, Markl B, Schaller T, Anthuber M, Fleischmann C, et al. Endoscopic submucosal dissection for early rectal neoplasia: experience from a European center. Endoscopy. 2017;49:222-32. doi: 10.1055/s-0042-118449. [PMID: 27842423].

Tanabe S, Hirabayashi S, Oda I, Ono H, Nashimoto A, Isobe Y, et al. Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013. Gastric Cancer. 2017;20:834-42. doi: 10.1007/s10120-017-0699-4. [PMID: 28205058].

Toya Y, Endo M, Nakamura S, Akasaka R, Kosaka T, Yanai S, et al. Clinical outcomes of non-curative endoscopic submucosal dissection with negative resected margins for gastric cancer. Gastrointest Endosc. 2017;85:1218-24. doi: 10.1016/j.gie.2016.11.018. [PMID: 27889547].

Sooltangos A, Davenport M, McGrath S, Vickers J, Senapati S, Akhtar K, et al. Gastric endoscopic submucosal dissection as a treatment for early neoplasia and for accurate staging of early cancers in a United Kingdom Caucasian population. World J Gastrointest Endosc. 2017;9:561-70. doi: 10.4253/wjge.v9.i12.561. [PMID: 29290911].

Shimodate Y, Nagahisa Y, Mizuno M. Transgastric endoscopic submucosal dissection of esophageal cancer with cervical stricture. Dig Endosc. 2018;30:389. doi: 10.1111/den.13033. [PMID: 29420854].

Tsuchida C, Yoshitake N, Kino H, Kaneko Y, Nakano M, Tsuchida K, et al. Clinical importance of colonoscopy in patients with gastric neoplasm undergoing endoscopic submucosal dissection. World J Gastroenterol. 2017;23:4262-9. doi: 10.3748/wjg.v23.i23.4262. [PMID: 28694666].

Zhou G, Yuan F, Cai J, Tang X, Gong W, Su L, et al. Efficacy of prednisone for prevention of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Thorac Cancer. 2017;8:489-94. doi: 10.1111/1759-7714.12473. [PMID: 28759148].

Lee S, Choi KD, Han M, Na HK, Ahn JY, Jung KW, et al. Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis. Gastric Cancer. 2018;21:490-9. doi: 10.1007/s10120-017-0772-z. [PMID: 29052052].

Ciocirlan M. Is the West finally reaching the East in endoscopic submucosal dissection? The gastric cancer case. Endoscopy. 2017;49:837-8. doi: 10.1055/s-0043-117735. [PMID: 28850975].

Ryu DG, Choi CW, Kang DH, Kim HW, Park SB, Kim SJ, et al. Clinical outcomes of endoscopic submucosa dissection for high-grade dysplasia from endoscopic forceps biopsy. Gastric Cancer. 2017;20:671-8. doi: 10.1007/s10120-016-0665-6. [PMID: 27822683].

Park JC, Park Y, Kim HK, Jo JH, Park CH, Kim EH, et al. Probe-based confocal laser endomicroscopy in the margin delineation of early gastric cancer for endoscopic submucosal dissection. J Gastroenterol Hepatol. 2017;32:1046-54. doi: 10.1111/jgh.13635. [PMID: 27862291].

Kawaguchi K, Kurumi H, Takeda Y, Yashima K, Isomoto H. Management of strictures after endoscopic submucosal dissection for superficial esophageal cancer. Ann Transl Med. 2017;5:184. doi: 10.21037/atm.2017.04.22. [PMID: 28616399].

Kang D, Ha SE, Park JM, Yoon SB, Lee HH, Lim CH, et al. Body Mass Index and Clinical Outcomes from Endoscopic Submucosal Dissection of Gastric Neoplasia. Dig Dis Sci. 2017;62:1657-65. doi: 10.1007/s10620-017-4560-8. [PMID: 28391415].

Tsuchiya I, Kato Y, Tanida E, Masui Y, Kato S, Nakajima A, et al. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial. Dig Endosc. 2017;29:576-83. doi: 10.1111/den.12857. [PMID: 28267236].

Nishizawa T, Yahagi N. Long-Term Outcomes of Using Endoscopic Submucosal Dissection to Treat Early Gastric Cancer. Gut Liver. 2018;12:119-24. doi: 10.5009/gnl17095. [PMID: 28673068].

Jeon HK, Kim GH, Lee BE, Park DY, Song GA, Kim DH, et al. Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis. Gastric Cancer. 2018;21:133-43. doi: 10.1007/s10120-017-0719-4. [PMID: 28397011].

Hu Q, Zhang Y, Zhang X, Fu K. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomark Res. 2016;4:15. doi: 10.1186/s40364-016-0068-1. [PMID: 27468353].

Qin J, Wang S, Wang P, Wang X, Ye H, Song C, et al. Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer. J Cancer Res Clin Oncol. 2019;145:1253-62. doi: 10.1007/s00432-019-02884-5. [PMID: 30887154].

Shen L, Huang Y, Sun M, Xu H, Wei W, Wu W. Clinicopathological features associated with lymph node metastasis in early gastric cancer: analysis of a single-institution experience in China. Can J Gastroenterol. 2009;23:353-6. doi: 10.1155/2009/462678. [PMID: 19440566].

Choi IJ, Lee JH, Kim YI, Kim CG, Cho SJ, Lee JY, et al. Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection. Gastrointest Endosc. 2015;81:333-41. doi: 10.1016/j.gie.2014.07.047. [PMID: 25281498].

Suzuki H, Oda I, Abe S, Sekiguchi M, Mori G, Nonaka S, et al. High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection. Gastric Cancer. 2016;19:198-205. doi: 10.1007/s10120-015-0469-0. [PMID: 25616808].